» Articles » PMID: 32875283

Negative Selection of Human T Cells Recognizing a Naturally-expressed Tissue-restricted Antigen in the Human Thymus

Overview
Date 2020 Sep 3
PMID 32875283
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

During T cell development in mice, thymic negative selection deletes cells with the potential to recognize and react to self-antigens. In human T cell-dependent autoimmune diseases such as Type 1 diabetes, multiple sclerosis, and rheumatoid arthritis, T cells reactive to autoantigens are thought to escape negative selection, traffic to the periphery and attack self-tissues. However, physiological thymic negative selection of autoreactive human T cells has not been previously studied. We now describe a human T-cell receptor-transgenic humanized mouse model that permits the study of autoreactive T-cell development in a human thymus. Our studies demonstrate that thymocytes expressing the autoreactive Clone 5 TCR, which recognizes insulin B:9-23 presented by HLA-DQ8, are efficiently negatively selected at the double and single positive stage in human immune systems derived from HLA-DQ8 HSCs. In the absence of hematopoietic expression of the HLA restriction element, negative selection of Clone 5 is less efficient and restricted to the single positive stage. To our knowledge, these data provide the first demonstration of negative selection of human T cells recognizing a naturally-expressed tissue-restricted antigen. Intrathymic antigen presenting cells are required to delete less mature thymocytes, while presentation by medullary thymic epithelial cells may be sufficient to delete more mature single positive cells. These observations set the stage for investigation of putative defects in negative selection in human autoimmune diseases.

Citing Articles

Neoantigen-based mRNA vaccine exhibits superior anti-tumor activity compared to synthetic long peptides in an in vivo lung carcinoma model.

Nguyen C, Vu T, Nguyen M, Tran-Nguyen T, Huynh C, Ha Q Cancer Immunol Immunother. 2025; 74(4):145.

PMID: 40072566 DOI: 10.1007/s00262-025-03992-7.


Immune Checkpoint Inhibitor-Associated Cutaneous Adverse Events: Mechanisms of Occurrence.

Eshaq A, Flanagan T, Ba Abbad A, Makarem Z, Bokir M, Alasheq A Int J Mol Sci. 2025; 26(1.

PMID: 39795946 PMC: 11719825. DOI: 10.3390/ijms26010088.


Modeling cell-mediated immunity in human type 1 diabetes by engineering autoreactive CD8 T cells.

Peters L, Yeh W, Arnoletti J, Brown M, Posgai A, Mathews C Front Immunol. 2023; 14:1142648.

PMID: 37325626 PMC: 10262917. DOI: 10.3389/fimmu.2023.1142648.


Humanized mouse models for immuno-oncology research.

Chuprin J, Buettner H, Seedhom M, Greiner D, Keck J, Ishikawa F Nat Rev Clin Oncol. 2023; 20(3):192-206.

PMID: 36635480 PMC: 10593256. DOI: 10.1038/s41571-022-00721-2.


The adaptation model of immunity: Is the goal of central tolerance to eliminate defective T cells or self-reactive T cells?.

Manjili M Scand J Immunol. 2022; 96(4):e13209.

PMID: 36239215 PMC: 9539632. DOI: 10.1111/sji.13209.


References
1.
Nagamine K, Peterson P, Scott H, Kudoh J, Minoshima S, Heino M . Positional cloning of the APECED gene. Nat Genet. 1997; 17(4):393-8. DOI: 10.1038/ng1297-393. View

2.
Lee T, Sprouse M, Banerjee P, Bettini M, Bettini M . Ectopic Expression of Self-Antigen Drives Regulatory T Cell Development and Not Deletion of Autoimmune T Cells. J Immunol. 2017; 199(7):2270-2278. PMC: 5605461. DOI: 10.4049/jimmunol.1700207. View

3.
Kurobe H, Liu C, Ueno T, Saito F, Ohigashi I, Seach N . CCR7-dependent cortex-to-medulla migration of positively selected thymocytes is essential for establishing central tolerance. Immunity. 2006; 24(2):165-77. DOI: 10.1016/j.immuni.2005.12.011. View

4.
Baldwin T, Hogquist K . Transcriptional analysis of clonal deletion in vivo. J Immunol. 2007; 179(2):837-44. DOI: 10.4049/jimmunol.179.2.837. View

5.
Eerligh P, van Lummel M, Zaldumbide A, Moustakas A, Duinkerken G, Bondinas G . Functional consequences of HLA-DQ8 homozygosity versus heterozygosity for islet autoimmunity in type 1 diabetes. Genes Immun. 2011; 12(6):415-27. DOI: 10.1038/gene.2011.24. View